My research contributes to the multi-disciplinary research streams of knowledge generation and innovation in knowledge-intense industries. My main areas of expertise include:

• Knowledge Generation and Innovation in Knowledge-intense Industries
• Alliances, Collaboration, and Innovation Networks
• Internationalization of Science and R&D
• Repurposing and Exaptation

My research has a strong focus on empirical projects that apply quantitative research designs using rich and large datasets, e.g., of scientific publications or clinical trials. Typically, I use different regression methods as well as social network analysis to analyze these datasets. However, I have recently commenced mixed-method studies that also use qualitative data.

Publications in Refereed Journals

• 2024
  • Hoekman, J. and Rake, B.: Geography of authorship: How geography shapes authorship attribution in big team science. Research Policy, 53(2), 104927.
• 2023
  • Rake, B., Sengupta, K., Lewin, L., Sandström, A., and McKelvey, M.: Doing science together: gaining momentum from long-term explorative university–industry research programs. Drug Discovery Today, 28(9), 103687.
• 2022
  • Rake, B.: Waiving intellectual property rights: Boom or bust for medical innovation?, Drug Discovery Today, 27(2), 384-389
• 2021
  • Hanisch, M. and Rake, B.: Repurposing without purpose? Early innovation responses to the COVID‐19 crisis: Evidence from clinical trials, R&D Management, 51(4), 393-409
  • Rake, B., D’Este, P. and McKelvey, M.: Exploring network dynamics in science: the formation of ties to knowledge translators in clinical research, Journal of Evolutionary Economics, 31(5), 1433–1464
  • Rake, B.: Do publication activities of academic institutions benefit from formal collaborations with firms?, Innovation: Organization & Management, 23(2), 241-265
• 2020
  • McKelvey, M. and Rake, B.: Exploring scientific publications by firms: what are the roles of academic and corporate partners for publications in high reputation or high impact journals?, Scientometrics, 122, 1323-1360
• 2019
  • Rake, B. and Häussler, C.: Did relaxing clinical trial regulation enhance the stock of scientific knowledge in India? Not necessarily, PLOS ONE, 14(1), e0210163
• 2017
  • Häussler, C. and Rake, B.: The Changing Geography of Clinical Research: A Critical Analysis of its Drivers, Industrial and Corporate Change, 26 (2), 285-310
  • Rake, B.: Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited, Journal of Evolutionary Economics, 24(4), 691–727
• 2016
  • McKelvey, M. and Rake, B.: Product Innovation Success Based on Cancer Research in the Pharmaceutical Industry: Co-publication Networks and the Effects of Partners, Industry and Innovation, 23(5), 383-406
• 2014
  • Cantner, U. and Rake, B.: International Research Networks in Pharmaceuticals: Structure and Dynamics, Research Policy, 43(2), 333-348
  • Plotnikova, T. and Rake, B.: Collaboration in Pharmaceutical Research: Exploration of Country-level Determinants, Scientometrics, 98(2), 1173-1202

Book Chapters

• 2023
  • Rake, B. and Hanisch, M., Repurposing: A Collaborative Innovation Strategy for the Digital Age, The PDMA Handbook of New Product Development, 04^th Edition, Editors Bstieler, L. and Noble, C., Wiley, 103-119
• 2022
  • Rake, B.: Controversies with Clinical Trial Regulations in Low- and Middle-Income Countries, In: Faintuch, J., Faintuch, S. (eds), Integrity of Scientific Research, Springer, Cham, 235–242, Abstract

Other Publications

• 2023
  • Hanisch, M. and Rake, B.: Repurposing: A Missed Opportunity for Innovation?, Blog Expertisecentrum Vinci, 19 January 2023
• 2022
  • Rake,B.: What Viagra tells us about sustainability and repurposing, RTÉ Brainstorm, 22 November 2022
• 2021
  • Hanisch, M. and Rake, B.: What can we learn from the COVID-19 drug and vaccine development?, Blog Expertisecentrum Vinci, 19 February 2021
• 2020
  • Rake, B.: Can contact tracing apps stop the pandemic?, Business&Society Blog, 25 June 2020
• 2019
  • Rake, B.: How to use LinkedIn more effectively, RTÉ Brainstorm, 21 May 2019

Editorships

• 12/2022 –
  • Academic Editor, PLOS ONE
• 01/2025 –
  • Guest Editor, Special Issue on Repurposing for Innovation: Navigating Technology, Uncertainty, and Sustainability in the Modern Business Landscape, Industry and Innovation, Co-editors: Bodas-Freitas, I.-M., Hanisch, M., Hu,Y. and Piaskowska, D.
• 06/2021 –
  • Guest Editor, Special Issue on Rethinking Medical Innovation: Organizing R&D, Responding to Crisis, Delivering Health Services, Innovation: Organization & Management, Co-editors: Gulbrandsen, M., McKelvey, M., and Miller, F. A.

Selected Presentations at Academic Conferences and Workshops

I have presented my research at more than thirty international conferences and workshops. In addition, I have been invited to give talks on more than five occasions at different institutions, including University College Dublin, University College London, and the University of Kassel.

Recent presentations include but are not limited to the following:

• 2024
  • Team Diversity and Success in Collaborative Research: Empirical Evidence from Grant Proposals in a Research Hospital, 20^th International Joseph A. Schumpeter Society Conference, Gothenburg (Sweden), 09^th – 11^th June
• 2023
  • The Specialist’s Dilemma: How Specialization Inhibits Reactivity and Innovation Responsiveness in a Crisis, Annual Meeting of Technology, Innovation, and Entrepreneurship Division (TIE Kommission) of the German Academic Association for Business Research (VHB), Frankfurt am Main (Germany), 21^st-22^nd September
• 2021
  • Geography of authorship: How geography shapes authorship attribution in global team science, 18^th International Joseph A. Schumpeter Society Conference, online conference, 08^th-10^th July
• 2019
  • Big Pharma, Bad Science? An Analysis of Retractions in Bio-medical Journals, 79^th Annual Meeting of the Academy of Management, Boston (United States), 9^th-13^th August
• 2018
  • Exploring Network Dynamics in Complex Fields of Science: Investigator Networks in Clinical Trials, 17^th International Joseph A. Schumpeter Society Conference, Seoul (South Korea), 02^nd-04^th July
• 2017
  • How Do Networks Affect Knowledge Generation for Drug Development? – A study of Investigator Networks, Knowledge Domains, and Knowledge Generation, Annual Meeting of Technology, Innovation, and Entrepreneurship Division (TIE Kommission) of the German Academic Association for Business Research (VHB), Koblenz (Germany), 21^st-22^nd September
  • How Do Networks Affect Knowledge Generation for Drug Development? – A study of Investigator Networks, Knowledge Domains, and Knowledge Generation, 77^th Annual Meeting of the Academy of Management, Atlanta (United States), 4^th-8^th August
• 2016
  • How Do Networks Affect Knowledge Generation for Drug Development?: Investigator Networks and Knowledge Generation in Clinical Trials, 16^th International Joseph A. Schumpeter Society Conference, Montreal (Canada), 6^th-8^th July